TR200000576T1 - Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem - Google Patents

Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Info

Publication number
TR200000576T1
TR200000576T1 TR2000/00576T TR200000576T TR200000576T1 TR 200000576 T1 TR200000576 T1 TR 200000576T1 TR 2000/00576 T TR2000/00576 T TR 2000/00576T TR 200000576 T TR200000576 T TR 200000576T TR 200000576 T1 TR200000576 T1 TR 200000576T1
Authority
TR
Turkey
Prior art keywords
liposomal encapsulated
applying
taxane
encapsulated taxane
liposomal
Prior art date
Application number
TR2000/00576T
Other languages
English (en)
Inventor
Rahman Aquilar
Original Assignee
Neopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm filed Critical Neopharm
Publication of TR200000576T1 publication Critical patent/TR200000576T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Kanser tedavisinde terapötik olarak gelistirilmis bir yöntemin uygulanmasinda kullanilan lipozomal kapsüllenmis taksan veya bir antineoplastik türevi veya bir karisimi saglanmaktadir. Lipozomal kapsüllenmis paclitaxel, bir toksisitle olmaksizin bir hastaya, özellikle bir insan hastaya bir saatten kisa bir sürede verilebilir.
TR2000/00576T 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem TR200000576T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane

Publications (1)

Publication Number Publication Date
TR200000576T1 true TR200000576T1 (tr) 2000-11-21

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00576T TR200000576T1 (tr) 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Country Status (17)

Country Link
US (1) US6146659A (tr)
EP (1) EP1009384A4 (tr)
JP (2) JP2001524990A (tr)
KR (1) KR20010023522A (tr)
CN (1) CN1275076A (tr)
AU (1) AU730599B2 (tr)
BR (1) BR9906581A (tr)
CA (1) CA2301057C (tr)
EA (1) EA003678B1 (tr)
HU (1) HUP0004583A3 (tr)
IL (1) IL134747A0 (tr)
NO (1) NO20001012L (tr)
NZ (1) NZ524490A (tr)
PL (1) PL338951A1 (tr)
SK (1) SK4642000A3 (tr)
TR (1) TR200000576T1 (tr)
WO (1) WO2000001366A1 (tr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6815173B1 (en) * 1999-06-09 2004-11-09 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting syphilis using synthetic antigents
HK1046506B (en) * 1999-09-09 2006-08-25 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
ATE341310T1 (de) * 2000-02-04 2006-10-15 Lipoxen Technologies Ltd Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
DE60136490D1 (de) 2000-11-09 2008-12-18 Neopharm Inc Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
CA2466443A1 (en) * 2001-11-09 2003-05-15 Neopharm, Inc. Selective treatment of il-13 expressing tumors
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
CA2484761C (en) 2002-05-24 2010-11-09 Angiotech International Ag Compositions and methods for coating medical implants
AU2003240934A1 (en) * 2002-05-29 2003-12-19 Neopharm, Inc. Method for determining oligonucleotide concentration
JP4454019B2 (ja) * 2002-07-15 2010-04-21 アルコン，インコーポレイテッド 眼薬送達のための生体侵食性フィルム
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
CN1700906A (zh) * 2003-02-03 2005-11-23 新药物公司 稳定的无菌过滤性脂质体包封的紫杉烷和其他抗肿瘤药物
EA200501285A1 (ru) * 2003-02-11 2006-02-24 Неофарм, Инк. Способ получения липосомальных препаратов
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
EP2286794B8 (en) 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Use of cationic liposomes comprising paclitaxel
PA8625301A1 (es) 2004-03-05 2006-06-02 Univ Florida State Res Found Taxanos con sustituyente lactiloxilo en el c7
PT1744764E (pt) * 2004-04-22 2012-08-30 Celator Pharmaceuticals Inc Formulações lipossómicas de agentes antraciclina e análogos de citidina
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
EP1811962A2 (en) * 2004-10-29 2007-08-01 Neopharm, Inc. Manufacturing process for liposomal preparations
JP2008519076A (ja) * 2004-11-02 2008-06-05 テルアビブ ユニバーシティ フューチャー テクノロジー デベロップメント エル．ピー． 脂質化グリコサミノグリカン粒子中の水不溶性又は水難溶性薬物の処方、並びに診断及び治療のためのこれらの使用
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
CA2605749C (en) 2005-04-26 2015-06-30 Eisai Co., Ltd. Compositions and methods for cancer immunotherapy
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
AU2007228984B2 (en) 2006-03-22 2012-05-03 Syncore Biotechnology Co., Ltd Treatment of triple receptor negative breast cancer
AU2007240317B2 (en) 2006-04-20 2012-11-29 Amgen Inc. Stable emulsion formulations
EP2088865B1 (en) 2006-11-06 2015-10-21 Jina Pharmaceuticals Inc. Guggulphospholipid methods and compositions
GB0905348D0 (en) 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2011038068A1 (en) * 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
KR20150095809A (ko) 2012-12-12 2015-08-21 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 치료용 조성물 및 방법
US20160128971A1 (en) * 2013-04-05 2016-05-12 Vuong Trieu Nanoparticle Compositions
WO2015038993A1 (en) * 2013-09-13 2015-03-19 Arbor Therapeutics, LLC Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
DE69329073T2 (de) * 1992-03-23 2001-01-18 Georgetown University, Washington In liposomen verkapseltes taxol und verwendungsverfahren
WO1994026254A1 (en) * 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation of taxol into liposomes and gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
DE69528077T2 (de) * 1994-11-18 2003-04-17 Aphios Corp., Woburn Verfahren zur Herstellung von Liposomen, die hydrophobische Artzneistoffe enthalten
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
IL123595A (en) * 1995-09-12 2000-10-31 Liposome Co Inc Hydrolysis-promoting taxane hydrophobic derivatives and pharmaceutical compositions containing them
CA2189916C (en) * 1996-11-08 2001-01-16 Parkash S. Gill A new regime for paclitaxel in kaposi's sarcoma patients

Also Published As

Publication number Publication date
BR9906581A (pt) 2000-09-26
WO2000001366A1 (en) 2000-01-13
HUP0004583A3 (en) 2002-04-29
JP2001524990A (ja) 2001-12-04
PL338951A1 (en) 2000-12-04
IL134747A0 (en) 2001-04-30
NO20001012L (no) 2000-03-15
KR20010023522A (ko) 2001-03-26
EA003678B1 (ru) 2003-08-28
AU5088099A (en) 2000-01-24
CA2301057C (en) 2009-03-10
NO20001012D0 (no) 2000-02-29
HUP0004583A2 (hu) 2001-08-28
JP2004059590A (ja) 2004-02-26
EA200000282A1 (ru) 2000-10-30
AU730599B2 (en) 2001-03-08
CA2301057A1 (en) 2000-01-13
EP1009384A4 (en) 2004-11-17
CN1275076A (zh) 2000-11-29
SK4642000A3 (en) 2000-11-07
NZ524490A (en) 2005-04-29
EP1009384A1 (en) 2000-06-21
US6146659A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
ATE312635T1 (de) Ventilanordnung
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
ATE329903T1 (de) Hochgradig lipophile camptothecin-derivate
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
PT1085884E (pt) Combinacao de compostos seleniferos com gemcitabina ou mitomicina c
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
NO20014812L (no) Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
ATE233745T1 (de) Arzneistoffe
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
IT1304342B1 (it) Composizione per il trattamento cosmetico topico della cellulite.
UA38148A (uk) Спосіб комплексного лікування коловидного облисіння
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien
TH10441B (th) การใช้อนุพันธ์เพรคเนม
SE9900891D0 (sv) Topical composition for dermatological and cosmetic treatment of the skin